BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1518161)

  • 1. [Recent advances in EDRF research].
    Shikano K
    Nihon Rinsho; 1992 Jun; 50(6):1430-6. PubMed ID: 1518161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
    Shikano K; Berkowitz BA
    J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative pharmacology of endothelium-derived relaxing factor and nitric oxide.
    Shikano K; Long CJ; Ohlstein EH; Berkowitz BA
    J Pharmacol Exp Ther; 1988 Dec; 247(3):873-81. PubMed ID: 2849673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide.
    Myers PR; Minor RL; Guerra R; Bates JN; Harrison DG
    Nature; 1990 May; 345(6271):161-3. PubMed ID: 2110626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
    Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
    J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
    Blaise GA; Stewart DJ; Guérard MJ
    Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
    Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
    Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
    Kuhn M; Otten A; Frölich JC; Förstermann U
    J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of production of endothelium-derived relaxing factor (EDRF) by cultured human vascular endothelial cells based on its anti-aggregatory effect on human platelets.
    Ohno M; Kishimoto T; Jidoi J; Tada M
    Hum Cell; 1994 Mar; 7(1):68-71. PubMed ID: 8025024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Release and properties of endothelium-derived relaxing factor (EDRF) from endothelial cells in culture.
    Cocks TM; Angus JA; Campbell JH; Campbell GR
    J Cell Physiol; 1985 Jun; 123(3):310-20. PubMed ID: 3886674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
    Myers PR; Wright TF; Tanner MA; Ostlund RE
    J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Abluminal release and asymmetrical response of the rabbit arterial wall to endothelium-derived relaxing factor.
    Bassenge E; Busse R; Pohl U
    Circ Res; 1987 Nov; 61(5 Pt 2):II68-73. PubMed ID: 3117407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
    Palmer RM; Ferrige AG; Moncada S
    Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Abnormal endothelium-mediated regulation of vascular tone in arteriosclerosis].
    Mügge A
    Z Kardiol; 1994 Oct; 83(10):759-67. PubMed ID: 7528959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
    Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
    Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EDRF and nitric oxide production in cultured endothelial cells: direct inhibition by E. coli endotoxin.
    Myers PR; Wright TF; Tanner MA; Adams HR
    Am J Physiol; 1992 Mar; 262(3 Pt 2):H710-8. PubMed ID: 1558180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding the controversy over the identity of EDRF.
    Feelisch M; te Poel M; Zamora R; Deussen A; Moncada S
    Nature; 1994 Mar; 368(6466):62-5. PubMed ID: 8107883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Introduction to EDRF research.
    Furchgott RF
    J Cardiovasc Pharmacol; 1993; 22 Suppl 7():S1-2. PubMed ID: 7504760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What is the relationship between the endothelium derived relaxant factor and nitric oxide?
    Long CJ; Berkowitz BA
    Life Sci; 1989; 45(1):1-14. PubMed ID: 2664391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor organ preservation fluids differ in their effect on endothelial cell function.
    Cullen S; Haworth SG; Warren JD
    J Heart Lung Transplant; 1991; 10(6):999-1003. PubMed ID: 1756167
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.